Terms: = Leukemia AND IGH AND Prognosis
122 results:
1. Prognostic Factors in Philadelphia Chromosome-Positive Acute Myeloid leukemia Using Fluorescence in Situ Hybridization.
Zhang Z; Sun C; Cai L; Chen Y; Zhou X; Chen S; Feng X; Yang X; Li Q; Liu L; Zhou H; Li B
Clin Lab; 2024 Feb; 70(2):. PubMed ID: 38345995
[TBL] [Abstract] [Full Text] [Related]
2. Novel identification of t(14;18)(q32;q21)/igh::MALT1 in chronic lymphocytic leukaemia.
Kumar J; Ewalt MD; Zhang Y; Yao J; Thompson MC; Dogan A
Br J Haematol; 2024 Feb; 204(2):561-565. PubMed ID: 38031233
[TBL] [Abstract] [Full Text] [Related]
3. Minimal residual disease detection by next-generation sequencing of different immunoglobulin gene rearrangements in pediatric B-ALL.
Chen H; Gu M; Liang J; Song H; Zhang J; Xu W; Zhao F; Shen D; Shen H; Liao C; Tang Y; Xu X
Nat Commun; 2023 Nov; 14(1):7468. PubMed ID: 37978187
[TBL] [Abstract] [Full Text] [Related]
4. Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop.
Quintanilla-Martinez L; Laurent C; Soma L; Ng SB; Climent F; Ondrejka SL; Zamo A; Wotherspoon A; de Leval L; Dirnhofer S; Leoncini L
Virchows Arch; 2023 Sep; 483(3):281-298. PubMed ID: 37555980
[TBL] [Abstract] [Full Text] [Related]
5. [Clinical characteristics of 11 patients with chronic lymphocytic leukemia with t (14;19) (q32;q13)].
Cui CH; Chang YN; Zhou J; Li CW; Wang HJ; Sun Q; Jia YJ; Li QH; Wang TY; Qiu LG; Yi SH
Zhonghua Xue Ye Xue Za Zhi; 2023 May; 44(5):418-423. PubMed ID: 37550193
[No Abstract] [Full Text] [Related]
6. igh 3'RR recombination uncovers a non-germinal center imprint and c-MYC-dependent igh rearrangement in unmutated chronic lymphocytic leukemia.
Al Jamal I; Parquet M; Guiyedi K; Aoufouchi S; Le Guillou M; Rizzo D; Pollet J; Dupont M; Boulin M; Faumont N; Boutouil H; Jardin F; Ruminy P; El Hamel C; Lerat J; Al Hamaoui S; Makdissy N; Feuillard J; Gachard N; Peron S
Haematologica; 2024 Feb; 109(2):466-478. PubMed ID: 37496419
[TBL] [Abstract] [Full Text] [Related]
7. Refining prognosis in chronic lymphocytic leukemia with normal Fluorescence in situ hybridization results.
Avenarius MR; Huang Y; Hyak J; Byrd JC; Bhat SA; Grever M; Kittai AS; Rogers KA; Jones D; Zhao W; Heerema NA; Abruzzo LV; Woyach J; Miller CR
Hematol Oncol; 2023 Oct; 41(4):771-775. PubMed ID: 37010242
[TBL] [Abstract] [Full Text] [Related]
8. [Clinical analysis of 20 cases of small B lymphocyte proliferative disease with t (14;19) (q32;q13)].
Yang H; Guo R; Shi Y; Qiao C; Wu YJ; Fan L; Xu W; Miao KR; Li JY; Qiu HR
Zhonghua Xue Ye Xue Za Zhi; 2022 Aug; 43(8):674-679. PubMed ID: 36709153
[No Abstract] [Full Text] [Related]
9. 5' Rapid amplification of cDNA ends (5'RACE): A simpler method to analyze immunoglobulin genes and discover the value of the light chain in chronic lymphocytic leukemia.
Lan X; Ruminy P; Bohers E; Rainville V; Viennot M; Viailly PJ; Etancelin P; Tilly H; Mihailescu S; Bouclet F; Leprêtre S; Jardin F
Leuk Res; 2022 Dec; 123():106952. PubMed ID: 36272389
[TBL] [Abstract] [Full Text] [Related]
10. High occurrence of CRLF2 abnormalities in Mexican children with B-cell acute lymphoblastic leukemia.
Juárez-Velázquez MDR; Moreno-Lorenzana DL; Martínez Anaya DA; Hernández Monterde EA; Aguilar-Hernández MM; Reyes-León A; Chávez-González MA; López Santiago N; Zapata Tarrés M; Juárez Villegas L; Rivera Sánchez N; Soto Lerma O; Vega-Vega L; Rivera Luna R; Pérez-Vera P
Cytokine; 2022 Jul; 155():155896. PubMed ID: 35537330
[TBL] [Abstract] [Full Text] [Related]
11. TRAF3 alterations are frequent in del-3'igh chronic lymphocytic leukemia patients and define a specific subgroup with adverse clinical features.
Pérez-Carretero C; Hernández-Sánchez M; González T; Quijada-Álamo M; Martín-Izquierdo M; Santos-Mínguez S; Miguel-García C; Vidal MJ; García-De-Coca A; Galende J; Pardal E; Aguilar C; Vargas-Pabón M; Dávila J; Gascón-Y-Marín I; Hernández-Rivas JÁ; Benito R; Hernández-Rivas JM; Rodríguez-Vicente AE
Am J Hematol; 2022 Jul; 97(7):903-914. PubMed ID: 35472012
[TBL] [Abstract] [Full Text] [Related]
12. Immunoglobulin heavy chain gene rearrangement in heavy chain deposition disease suggests it is a plasma cell disease: a case report.
Rao Q; Xu R; Wan Q
J Int Med Res; 2022 Mar; 50(3):3000605221086428. PubMed ID: 35301906
[TBL] [Abstract] [Full Text] [Related]
13. High-risk subtypes of chronic lymphocytic leukemia are detectable as early as 16 years prior to diagnosis.
Kolijn PM; Hosnijeh FS; Späth F; Hengeveld PJ; Agathangelidis A; Saleh M; Casabonne D; Benavente Y; Jerkeman M; Agudo A; Barricarte A; Besson C; Sánchez MJ; Chirlaque MD; Masala G; Sacerdote C; Grioni S; Schulze MB; Nieters A; Engelfriet P; Hultdin M; McKay JD; Vermeulen RCH; Langerak AW
Blood; 2022 Mar; 139(10):1557-1563. PubMed ID: 34662377
[TBL] [Abstract] [Full Text] [Related]
14. [Molecular pathogenesis and treatment of chronic lymphocytic leukemia].
Suzuki R
Rinsho Ketsueki; 2021; 62(8):1085-1093. PubMed ID: 34497195
[TBL] [Abstract] [Full Text] [Related]
15. Role of cytogenetic abnormalities detected by fluorescence
Shetty D; Jain H; Rohil Y; Khattry N; Sengar M; Bagal B; Jain H; Gokarn A; Punatar S; Avinash Bonda VN; Subramanian PG
Indian J Med Res; 2021 Apr; 153(4):475-483. PubMed ID: 34380794
[TBL] [Abstract] [Full Text] [Related]
16. Morphologic and molecular analysis of Richter syndrome in chronic lymphocytic leukaemia patients treated with ibrutinib or venetoclax.
Gángó A; Kiss R; Farkas P; Hanna E; Demeter J; Deák B; Lévai D; Kotmayer L; Alpár D; Matolcsy A; Bödör C; Mátrai Z; Timár B
Pathology; 2022 Feb; 54(1):95-103. PubMed ID: 34332791
[TBL] [Abstract] [Full Text] [Related]
17. Frequency, variations, and prognostic implications of chromosome 14q32 deletions in chronic lymphocytic leukemia.
Harris RA; Stevens JM; Pickering DL; Althof PA; Smith LM; Sanmann JN; Dave BJ
Leuk Res; 2021 Nov; 110():106665. PubMed ID: 34293710
[TBL] [Abstract] [Full Text] [Related]
18. Extramedullary multiple myeloma patient-derived orthotopic xenograft with a highly altered genome: combined molecular and therapeutic studies.
Farre L; Sanz G; Ruiz-Xivillé N; Castro de Moura M; Martin-Tejera JF; Gonçalves-Ribeiro S; Martinez-Iniesta M; Calaf M; Luis Mosquera J; Martín-Subero JI; Granada I; Esteller M; Domingo-Domenech E; Climent F; Villanueva A; Sureda A
Dis Model Mech; 2021 Jul; 14(7):. PubMed ID: 33988237
[TBL] [Abstract] [Full Text] [Related]
19. Establishment of a typing model for diffuse large B-cell lymphoma based on B-cell receptor repertoire sequencing.
Jiang W; Wang H; Zhou S; Zhu G; Gao M; Zhao K; Zhang L; Xie X; Zhao N; Tian C; Zhang Z; Yan F; Pan Y; Liu P
BMC Cancer; 2021 Mar; 21(1):297. PubMed ID: 33752626
[TBL] [Abstract] [Full Text] [Related]
20. Identification of novel, clonally stable, somatic mutations targeting transcription factors PAX5 and NKX2-3, the epigenetic regulator LRIF1, and BRAF in a case of atypical B-cell chronic lymphocytic leukemia harboring a t(14;18)(q32;q21).
Burlet B; Ramla S; Fournier C; Abrey-Recalde MJ; Sauter C; Chrétien ML; Rossi C; Duffourd Y; Ragot S; Buriller C; Tournier B; Chapusot C; Nadal N; Racine J; Guy J; Bailly F; Martin L; Casasnovas O; Bastie JN; Caillot D; Albuisson J; Broccardo C; Thieblemont C; Delva L; Maynadié M; Aucagne R; Callanan MB
Cold Spring Harb Mol Case Stud; 2021 Feb; 7(1):. PubMed ID: 33608382
[TBL] [Abstract] [Full Text] [Related]
[Next]
